In Vivo PK & Safety Assessment

At Pharmacology Discovery Services, we leverage over 50 years of expertise to offer specialized in vivo non-GLP preclinical pharmacokinetics (PK), and safety and toxicology evaluations for drug discovery. Our skilled team, including experienced Technical Directors, Study Directors, and Scientific & Operational Teams, is committed to a thorough understanding of your candidate's properties, aiming to provide optimal dosing and sampling strategies. As a CRO, we integrate in vivo PK data with comprehensive safety and toxicity assessments, delivering essential insights for your drug development process

In Vitro Products & Services for Drug Discovery

Pharmacology Discovery Services is a Partner Lab of Eurofins Discovery. For >40 years, Eurofins Discovery network of companies has been a trusted CRO supporting global Drug Discovery clients from Target ID through to Candidate Selection. Eurofins Discovery was built by bringing together the market leading drug discovery expertise of Panlabs, Cerep, EMD Millipore's Discovery & Development Solutions business, and Villapharma Research.

Available in vitro PK & Safety services include over 150 ADME-Tox assays and an in vitro safety pharmacology portfolio that includes thousands of assays. Additional services include cell-based phenotypic assays, safety & efficacy, chemistry and custom proteins & assay development services. This partnership grants our clients access to a broad portfolio of drug discovery products and services to help advance their drug candidates to the clinic.